Skip to main content

Breast Cancer

Ausgabe 2/2024

Inhalt (19 Artikel)

Open Access Special Article

The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition

Kazunori Kubota, Kazutaka Nakashima, Kazuaki Nakashima, Masako Kataoka, Kenich Inoue, Mariko Goto, Chizuko Kanbayashi, Koichi Hirokaga, Ken Yamaguchi, Akihiko Suzuki

Open Access Correction

Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition

Kazunori Kubota, Kazutaka Nakashima, Kazuaki Nakashima, Masako Kataoka, Kenich Inoue, Mariko Goto, Chizuko Kanbayashi, Koichi Hirokaga, Ken Yamaguchi, Yusuke Ohta, Akihiko Suzuki

Open Access Special Article

The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition

Masaaki Kawai, Shoichiro Ohtani, Motoki Iwasaki, Seiichiro Yamamoto, Kiyoshi Takamatsu, Hitoshi Okamura, Masami Arai, Tsunehisa Nomura, Shinji Ozaki, Ken-ichi Shibata, Ayaka Akabane, Fuyuhiko Motoi, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji

Special Article

2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan

Yasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, Minoru Miyashita, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Naoko Kinukawa, Chie Watanabe, Masakazu Toi, Shigehira Saji

Special Article

Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry

Takayuki Iwamoto, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Minoru Miyashita, Takaaki Konishi, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji

Open Access Review Article

Advances in the study of autophagy in breast cancer

Tang Yu, Liu Rui, Zhao Jiumei, Li Ziwei, Hu Ying

Original Article

Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan

Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I. Lai, Ling-Ming Tseng, Chi-Cheng Huang

Original Article

The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening

Akira Nakamura, Koji Ohnuki, Haruka Takahashi, Shin Usami, Yuki Ishida, Setsuko Shibata, Akiko Umemura, Yuka Takikawa, Atsushi Kano

Original Article

Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale

Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura, Chikako Shimizu, Tomoko Taniyama, Manami Tada, Nao Yoshida, Hitomi Sato, Kiyomi Nonogaki, Kazumasa Yamamoto, Taro Yamanaka, Rika Kizawa, Takeshi Yamaguchi, Kiyo Tanaka, Yoko Kobayashi, Nobuko Tamura, Yuko Tanabe, Yuji Miura, Yuichiro Kikawa, Juhee Cho, Hidetaka Kawabata

Original Article

Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study

Xin Wu, Yu Gui, Jing Liu, Shichao Li, Xi Yang, Zhen Zeng, Yi Zhang, Linjun Fan, Jun Jiang, Li Chen

Open Access Original Article

The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience

Yi-Wen Hong, I-Ming Kuo, Wen-Ling Kuo, Chi-Chang Yu, Shih-Che Shen, Hsiu-Pei Tsai, Chia-Hui Chu, Hui-Yu Ho, Yung-Feng Lo, Shin-Cheh Chen, Yung-Chang Lin, Chih-Ying Chien, Hsu-Huan Chou

Original Article

Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence

Fatemeh Kazemzadeh, J. A. A. Snoek, Quirinus J. Voorham, Martijn G. H. van Oijen, Niek Hugen, Iris D. Nagtegaal

Original Article

Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre

Han Hsi Wong, Elena Cojocaru, James Watkins, Sujil James, Tony Aloysius, Jennifer Harrington, Gail Horan, Helen Hatcher

Original Article

Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy

Naruto Taira, Yuichiro Kikawa, Takayuki Iwamoto, Yuichiro Miyoshi, Kyoko Hara, Seiji Yoshitomi, Hajime Hikino, Hirotoshi Takahashi, Daisuke Takabatake, Shinichiro Kubo, Masahiko Ikeda, Hiroyoshi Doihara, Tadahiko Shien, Hiromi Okuyama, Yuko Tanabe, Fumikata Hara, Kosho Yamanouchi, Yasuhiro Hagiwara, Masataka Sawaki

Original Article

Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes

Wu Ding, Dengfeng Ye, Haifeng Chen, Yingli Lin, Zhian Li, Chuanjian Tu

Open Access Original Article

Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer

Nobuhiro Hoshi, Takefumi Uemura, Kazunoshin Tachibana, Sadahiko Abe, Yuko Murakami-Nishimagi, Maiko Okano, Masaru Noda, Katsuharu Saito, Koji Kono, Tohru Ohtake, Satoshi Waguri

Original Article

Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer

Jie-Yin Zhuang, Ze-Nan Huang, Zi-Jin Weng, Meng-Meng Liu, Xiang-Qi Huang, Dan He, Chun-Kui Shao, Min Dong

Original Article

Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy

Mikiko Kasahara, Sayaka Kanematsu, Yoshihito Tanaka, Satoshi Okazaki, Masahiro Watatani

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.